2021 ACR适宜性标准:感染性心内膜炎

2021-05-10 美国放射学会 J Am Coll Radiol

2021年5月,美国放射学会(ACR)发布了感染性心内膜炎的影像学检查标准。感染性心内膜炎可累计正常、异常以及人工心脏瓣膜。诊断主要结合临床表现和超声心动图检查结果。

中文标题:

2021 ACR适宜性标准:感染性心内膜炎

英文标题:

ACR Appropriateness Criteria® Infective Endocarditis

发布机构:

美国放射学会

发布日期:

2021-05-10

简要介绍:

2021年5月,美国放射学会(ACR)发布了感染性心内膜炎的影像学检查标准。感染性心内膜炎可累计正常、异常以及人工心脏瓣膜。诊断主要结合临床表现和超声心动图检查结果。影像学检查在感染性心内膜炎的初始诊断、并发症鉴别、预后判断以及进一步的治疗中起着重要作用。本文主要介绍了感染性心内膜炎的适宜性影像学检查。

相关资料下载:
[AttachmentFileName(sort=1, fileName=2021 ACR适宜性标准:感染性心内膜炎.pdf)] GetToolGuiderByIdResponse(projectId=1, id=0f68a1c0022299d0, title=2021 ACR适宜性标准:感染性心内膜炎, enTitle=ACR Appropriateness Criteria® Infective Endocarditis, guiderFrom=J Am Coll Radiol, authorId=0, author=, summary=2021年5月,美国放射学会(ACR)发布了感染性心内膜炎的影像学检查标准。感染性心内膜炎可累计正常、异常以及人工心脏瓣膜。诊断主要结合临床表现和超声心动图检查结果。, cover=https://img.medsci.cn/20211022/1634913243133_1608702.jpg, journalId=0, articlesId=null, associationId=191, associationName=美国放射学会, associationIntro=美国放射学会(American College of Radiology)拥有会员超过34,000名,包括美国放射医师,放射肿瘤学家,物理学家介入医师及核医学医师。其指南按放射检查的方法分类,共十组,每组下包括指南十余篇。同时向NGC提供了近200篇指南。学会拥有《ACR Bulletin》及《JACR》两本官方期刊。, copyright=0, guiderPublishedTime=Mon May 10 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2021年5月,美国放射学会(ACR)发布了感染性心内膜炎的影像学检查标准。感染性心内膜炎可累计正常、异常以及人工心脏瓣膜。诊断主要结合临床表现和超声心动图检查结果。影像学检查在感染性心内膜炎的初始诊断、并发症鉴别、预后判断以及进一步的治疗中起着重要作用。本文主要介绍了感染性心内膜炎的适宜性影像学检查。</span></p>, tagList=[TagDto(tagId=4248, tagName=感染性心内膜炎)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=24, categoryName=胸心外科, tenant=100), CategoryDto(categoryId=40, categoryName=影像放射, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=4248, guiderKeyword=感染性心内膜炎, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=2, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=34680, appHits=159, showAppHits=0, pcHits=792, showPcHits=34520, likes=0, shares=4, comments=13, approvalStatus=1, publishedTime=Fri Oct 22 22:58:24 CST 2021, publishedTimeString=2021-05-10, pcVisible=1, appVisible=1, editorId=1614372, editor=MedSciZeng, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=dajiong, createdTime=Fri Oct 22 22:40:33 CST 2021, updatedBy=1614372, updatedName=MedSciZeng, updatedTime=Tue Jan 02 18:46:17 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 ACR适宜性标准:感染性心内膜炎.pdf)])
2021 ACR适宜性标准:感染性心内膜炎.pdf
下载请点击:
评论区 (11)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1198126, encodeId=2658119812678, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=278c5152916, createdName=1469dc44m86暂无昵称, createdTime=Mon Feb 28 19:57:07 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080482, encodeId=0936108048273, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bf85595970, createdName=ms7000001397100582, createdTime=Thu Dec 16 00:08:05 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065610, encodeId=ea40106561006, content=<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>诊断标准, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cdd51992964, createdName=1e1ac4a1m23(暂无匿称), createdTime=Sun Oct 31 21:17:55 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065477, encodeId=592b10654e7fb, content=哎呦,不错你, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1db85479970, createdName=ms8000001416021409, createdTime=Sun Oct 31 10:08:20 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064680, encodeId=f00c106468021, content=好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=514d5556399, createdName=谷芬, createdTime=Thu Oct 28 15:00:05 CST 2021, time=2021-10-28, status=1, ipAttribution=)]
    2022-02-28 1469dc44m86暂无昵称

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1198126, encodeId=2658119812678, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=278c5152916, createdName=1469dc44m86暂无昵称, createdTime=Mon Feb 28 19:57:07 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080482, encodeId=0936108048273, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bf85595970, createdName=ms7000001397100582, createdTime=Thu Dec 16 00:08:05 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065610, encodeId=ea40106561006, content=<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>诊断标准, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cdd51992964, createdName=1e1ac4a1m23(暂无匿称), createdTime=Sun Oct 31 21:17:55 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065477, encodeId=592b10654e7fb, content=哎呦,不错你, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1db85479970, createdName=ms8000001416021409, createdTime=Sun Oct 31 10:08:20 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064680, encodeId=f00c106468021, content=好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=514d5556399, createdName=谷芬, createdTime=Thu Oct 28 15:00:05 CST 2021, time=2021-10-28, status=1, ipAttribution=)]
    2021-12-16 ms7000001397100582

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1198126, encodeId=2658119812678, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=278c5152916, createdName=1469dc44m86暂无昵称, createdTime=Mon Feb 28 19:57:07 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080482, encodeId=0936108048273, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bf85595970, createdName=ms7000001397100582, createdTime=Thu Dec 16 00:08:05 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065610, encodeId=ea40106561006, content=<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>诊断标准, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cdd51992964, createdName=1e1ac4a1m23(暂无匿称), createdTime=Sun Oct 31 21:17:55 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065477, encodeId=592b10654e7fb, content=哎呦,不错你, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1db85479970, createdName=ms8000001416021409, createdTime=Sun Oct 31 10:08:20 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064680, encodeId=f00c106468021, content=好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=514d5556399, createdName=谷芬, createdTime=Thu Oct 28 15:00:05 CST 2021, time=2021-10-28, status=1, ipAttribution=)]
    2021-10-31 1e1ac4a1m23(暂无匿称)

    #心血管#诊断标准

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1198126, encodeId=2658119812678, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=278c5152916, createdName=1469dc44m86暂无昵称, createdTime=Mon Feb 28 19:57:07 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080482, encodeId=0936108048273, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bf85595970, createdName=ms7000001397100582, createdTime=Thu Dec 16 00:08:05 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065610, encodeId=ea40106561006, content=<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>诊断标准, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cdd51992964, createdName=1e1ac4a1m23(暂无匿称), createdTime=Sun Oct 31 21:17:55 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065477, encodeId=592b10654e7fb, content=哎呦,不错你, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1db85479970, createdName=ms8000001416021409, createdTime=Sun Oct 31 10:08:20 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064680, encodeId=f00c106468021, content=好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=514d5556399, createdName=谷芬, createdTime=Thu Oct 28 15:00:05 CST 2021, time=2021-10-28, status=1, ipAttribution=)]
    2021-10-31 ms8000001416021409

    哎呦,不错你

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1198126, encodeId=2658119812678, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=278c5152916, createdName=1469dc44m86暂无昵称, createdTime=Mon Feb 28 19:57:07 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080482, encodeId=0936108048273, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bf85595970, createdName=ms7000001397100582, createdTime=Thu Dec 16 00:08:05 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065610, encodeId=ea40106561006, content=<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>诊断标准, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cdd51992964, createdName=1e1ac4a1m23(暂无匿称), createdTime=Sun Oct 31 21:17:55 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065477, encodeId=592b10654e7fb, content=哎呦,不错你, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1db85479970, createdName=ms8000001416021409, createdTime=Sun Oct 31 10:08:20 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064680, encodeId=f00c106468021, content=好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=514d5556399, createdName=谷芬, createdTime=Thu Oct 28 15:00:05 CST 2021, time=2021-10-28, status=1, ipAttribution=)]
    2021-10-28 谷芬

    好好

    0

拓展阅读

2015 AHA科学声明:成人感染性心内膜炎的诊断、抗菌治疗及并发症管理

美国心脏协会(AHA,American Heart Association) · 2015-09-15

2015 AHA科学声明:儿童时期感染性心内膜炎(更新版)

美国心脏协会(AHA,American Heart Association) · 2015-09-15

2015 ESC指南:感染性心内膜炎的管理

欧洲心脏病学会(ESC,European Society of Cardiology) · 2015-08-29

JCS指南:感染性心内膜炎的预防和治疗

日本循环学会(JCS,Japanese Circulation Society) · 2019-07-05

2021 AHA科学声明:草绿色链球菌感染性心内膜炎的预防

美国心脏协会(AHA,American Heart Association) · 2021-04-15